iQ3Corp Ltd

ASX:IQ3 ISIN:AU000000IQ36

iQ3Corp LtdiQ3Corp Ltd (ASX:IQ3) is the world's first specialised life science corporate financial advisory and asset management firm.

iQ3Corp capitalises on its relationship with The iQ Group Global Companies and other industry participants such as academic institutions, financial market participants and other Life Science industry bodies, to provide a turnkey solution for capital raising from corporate inception to the capital markets.

iQ3 provides advice to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments, and individuals.

 
    
 

View in Other Languages

News

iQ3Corp Ltd (ASX:IQ3) Appointment to Advise Investment Consortium Developing First in Class Novel Biologic Compound and Biomarker

🕔4/5/2016 12:53:44 PM 5263

iQ3Corp Ltd (ASX:iQ3) is pleased to announce that it has syndicated an investor consortium which include iQ Group Global entities, to enter into a joint venture to develop and commercialise a first in class oncology, novel biologic compound and biomarker.

Read Full Article

iQ3Corp Ltd (ASX:IQ3) Half Yearly Report and Accounts

🕔2/29/2016 4:00:22 PM 4073

iQ3Corp Ltd (ASX:IQ3) present their report, together with the financial statements of the Group, being the Company and its controlled entities, for the half-year ended 31 December 2015.

Read Full Article

iQ3Corp Ltd (ASX:IQ3) Appointment as Corporate Advisor for the Acquisition of Emedia Creative

🕔11/17/2015 10:58:52 AM 5040

iQ3Corp Ltd (ASX:iQ3) is pleased to announce that it has today been appointed to act as corporate advisor to the parties to the in Principal Agreement by iQnovate Limited (IQN) to acquire a 50% equity stake in Emedia Creative Pty Ltd (Emedia) and the proposed listing of Emedia on the ASX.

Read Full Article

iQ3Corp Ltd (ASX:IQ3) Chairman's Address to Shareholders - 2015 AGM

🕔11/16/2015 7:34:42 PM 4370

iQ3Corp Ltd (ASX:IQ3) are pleased to provide the Chairman's Address to Shareholders at the 2015 Annual General Meeting (AGM).

Read Full Article

iQ3Corp Ltd (ASX:IQ3) Appointment of Head of US Investment Banking Operations

🕔9/9/2015 11:00:23 AM 5666

iQ3Corp Ltd (ASX:iQ3) is pleased to announce the appointment of Mr. David Batista to head up the investment banking operations of its U.S. subsidiary, iQ Capital LLC, based in New York.

Read Full Article

iQ3Corp Ltd (ASX:IQ3) App 4E / Full Year Statutory Accounts

🕔8/31/2015 12:04:33 PM 4630

iQ3Corp Ltd (ASX:IQ3) are pleased to present the operational and financial review for iQ3Corp Limited for the financial year ending 30th June 2015.

Read Full Article

iQ3Corp Ltd (ASX:IQ3) Announces Investment Banking Arm

🕔8/19/2015 11:15:28 AM 5579

iQ3Corp Ltd (ASX:IQ3) today announced that through its fully owned subsidiary in the U.S., iQ Capital LLC, it is applying to obtain the necessary licenses to operate an investment banking business dedicated to life sciences.

Read Full Article
###

12,052 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 11) (Last 30 Days: 56) (Since Published: 8097) 

Company Data

    Headquarters
  • Level 6, 222 Clarence Street
    Sydney NSW 2000
    Australia
  • Telephone
  • +61-2-8239-5400 
  • Fax
  • +61-2-8362-9325 
  • Principal Sector
  • Health & Pharm General 
  • Principal Industry
  • Financial Services 
  • Homepage
  • www.iq3corp.com
  • E:
  • info@iq3corp.com

Company Reports

Social Media